Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines

Vaccinations are effective in preventing infections; however, it is unknown if patients with chronic lymphocytic leukemia (CLL) who are treatment naïve (TN) or receiving Bruton tyrosine kinase inhibitors (BTKi's) respond to novel adjuvanted vaccines. Understanding the effect of BTKi's on h...

Descripción completa

Detalles Bibliográficos
Autores principales: Pleyer, Christopher, Ali, Mir A., Cohen, Jeffrey I., Tian, Xin, Soto, Susan, Ahn, Inhye E., Gaglione, Erika M., Nierman, Pia, Marti, Gerald E., Hesdorffer, Charles, Lotter, Jennifer, Superata, Jeanine, Wiestner, Adrian, Sun, Clare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820878/
https://www.ncbi.nlm.nih.gov/pubmed/33259596
http://dx.doi.org/10.1182/blood.2020008758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820878/
https://www.ncbi.nlm.nih.gov/pubmed/33259596
http://dx.doi.org/10.1182/blood.2020008758

Ejemplares similares